Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis.
Future Oncol. 2022 Sep;18(27):2987-2997. doi: 10.2217/fon-2022-0484. Epub 2022 Aug 11.
Future Oncol. 2022.
PMID: 35950489
Free article.
Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats.
Akhani SP, Vishwakarma SL, Goyal RK.
Akhani SP, et al.
J Pharm Pharmacol. 2004 Jan;56(1):101-5. doi: 10.1211/0022357022403.
J Pharm Pharmacol. 2004.
PMID: 14980006
Item in Clipboard
Cite
Cite